Vintrypsine injection with bacteria poison withdrawn

The Drug Administration of Vietnam under the Ministry of Health announced yesterday about the nationwide withdrawal of lyophilized injectable powder Vintrypsine (Alpha chymotrypsin 5000 units USP), manufactured by Vinh Phuc Pharmaceutical Joint Stock Company (Vinphaco).

Lyophilized injectable powder Vintrypsine. Photo from vinphaco.com.vn

Lyophilized injectable powder Vintrypsine. Photo from vinphaco.com.vn

The drug is withdrawn because it cannot meet the quality requirement on the criterion of lipopolysaccharide in the solvent.

The Drug Administration of Vietnam requested that Vinphaco cooperates with its distributors to send notice to all wholesalers, retailers, and users nationwide of the mentioned drug about the withdrawal.

The batch of below-standard injection must be immediately taken back, and proper reports on the task as well as proofs of this activity must be prepared.

The Departments of Health in Hanoi and Vinh Phuc Province are asked to monitor Vinphaco when carrying out this task in accordance with related regulations.

Other departments of Health in provinces and cities also need to issue notice to all pharmaceutical businesses and users about the drug withdrawal.

Vintrypsine injection is normally used to reduce inflammation of soft tissue due to abscess or injuries. It is also used to decrease respiratory secretions for patients of asthma, bronchitis, sinusitis, and other respiratory diseases.

By MINH KHANG – Translated by Vien Hong

Other news

Most view

Heart diseases culprit of thirty percent of deaths in Vietnam

Heart diseases culprit of thirty percent of deaths in Vietnam

Cardiovascular diseases are also responsible for 30 percent of deaths in Vietnam, said Deputy Head of the Department of Preventive Medicine Truong Dinh Bac at a yesterday meeting in Hanoi held by Vietnamese Ministry of Health and the World Health Organization.